Sale!

MYH7B Gene Cardiomyopathy Left Ventricular Noncompaction NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MYH7B Gene Cardiomyopathy Left Ventricular Noncompaction NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the MYH7B gene associated with left ventricular noncompaction cardiomyopathy. This comprehensive genetic analysis helps detect inherited heart muscle disorders characterized by abnormal trabeculations in the left ventricle. The test provides crucial information for early diagnosis, family screening, and personalized treatment planning. Using next-generation sequencing technology, it offers high accuracy in detecting pathogenic variants that can lead to heart failure, arrhythmias, and sudden cardiac death. For just $500 USD, patients gain access to advanced genetic insights that can guide clinical management and improve long-term cardiovascular outcomes.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MYH7B Gene Cardiomyopathy Left Ventricular Noncompaction NGS Genetic DNA Test

Understanding MYH7B Gene Cardiomyopathy and Left Ventricular Noncompaction

MYH7B Gene Cardiomyopathy Left Ventricular Noncompaction represents a significant genetic heart condition characterized by abnormal development of the left ventricular myocardium. This specialized NGS Genetic DNA Test provides comprehensive analysis of the MYH7B gene, which encodes the beta-myosin heavy chain protein essential for proper cardiac muscle contraction and function. Left ventricular noncompaction (LVNC) is a rare congenital cardiomyopathy where the heart muscle develops with excessive trabeculations and deep recesses, creating a spongy appearance that can compromise cardiac efficiency and increase the risk of serious complications.

What This Advanced Genetic Test Detects

Our cutting-edge NGS Genetic DNA Test specifically targets mutations in the MYH7B gene that are known to cause left ventricular noncompaction cardiomyopathy. The test identifies:

  • Pathogenic variants in the MYH7B gene affecting beta-myosin heavy chain production
  • Missense mutations that alter protein structure and function
  • Frameshift mutations leading to truncated proteins
  • Splice site variants affecting gene expression
  • Copy number variations impacting gene dosage

Who Should Consider This Genetic Test

This comprehensive genetic analysis is recommended for individuals experiencing:

  • Unexplained heart failure symptoms at a young age
  • Family history of cardiomyopathy or sudden cardiac death
  • Abnormal echocardiogram findings showing prominent trabeculations
  • Arrhythmias or palpitations without clear cause
  • Exercise intolerance or unexplained fatigue
  • History of syncope or near-fainting episodes
  • Children with developmental delays and cardiac concerns

Significant Benefits of Genetic Testing

Early detection through genetic testing provides numerous advantages:

  • Enables proactive management and treatment planning
  • Facilitates family screening and genetic counseling
  • Guides appropriate medication and lifestyle recommendations
  • Helps prevent sudden cardiac events through early intervention
  • Provides clarity for family planning decisions
  • Reduces diagnostic uncertainty and unnecessary testing

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and cardiologists:

  • Positive Result: Indicates a pathogenic mutation in the MYH7B gene, confirming genetic predisposition to LVNC. This requires comprehensive cardiac evaluation and regular monitoring.
  • Negative Result: No disease-causing mutation detected, though clinical follow-up may still be recommended based on symptoms and family history.
  • Variant of Uncertain Significance (VUS): A genetic change with unclear clinical significance requiring additional family studies and periodic re-evaluation.

Test Details and Pricing

Test Component Details
Test Name MYH7B Gene Cardiomyopathy Left Ventricular Noncompaction NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Specialty Cardiologist
Department Genetics
Method NGS Technology
Disease Type Cardiovascular Pneumology Disorders

Pre-Test Requirements

Before scheduling your test, please ensure you have:

  • Complete clinical history documenting cardiac symptoms and family background
  • Genetic counseling session to create detailed pedigree chart of affected family members
  • Recent cardiac evaluations including echocardiogram and ECG when available
  • Informed consent for genetic testing and result disclosure

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art genetic testing facilities ensure consistent, high-quality results regardless of your location.

Take Control of Your Heart Health Today

Don’t wait to get the answers you need about your cardiac health. Our MYH7B Gene Cardiomyopathy Left Ventricular Noncompaction NGS Genetic DNA Test provides the comprehensive genetic insights necessary for informed medical decisions and proactive health management. Early detection can significantly impact treatment outcomes and quality of life.

Ready to schedule your test? Call our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic heart health with confidence and clarity.